Changes in Beneficial Ownership · 4
OrthoPediatrics Corp.
KIDSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1788297228.xml
Filing details
- Report period
- 2026-08-28
- Issuer
- ORTHOPEDIATRICS CORP
- Issuer CIK
- 0001425450
- Trading symbol
- KIDS
Reporting owner 1
- Name
- Pelizzon David R
- Reporting owner CIK
- 0001719217
- Relationship
- Director · 10% owner
- Address
- C/O SQUADRON CAPITAL LLC, 18 HARTFORD AVE., PO BOX 223, GRANBY, CT, 06035
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-28 | S · Form 4[F1] | 326,700 | D | 23.04[F2] | 6,536,764 | I | See footnote[F3] |
| Common Stock | 2026-09-01 | S · Form 4[F1] | 10,131 | D | 23.10[F4] | 6,526,633 | I | See footnote[F3] |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Disposed
- I
- Indirect
Non-derivative holdings
| Security | Amount owned | Ownership |
|---|---|---|
| Common Stock | 44,384[F5] | D |
Table key
- D
- Direct
Footnotes
- F1
- This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.↩ 1↩ 2
- F2
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.↩ 1
- F3
- These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.↩ 1↩ 2
- F4
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.↩ 1
- F5
- Includes restricted stock awards totaling 17,959 shares.↩ 1
Signature 1
- Signed
- /s/ Daniel J. Gerritzen, Attorney-in-Fact
- Date
- 2026-09-01